We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

157 hedge funds and large institutions have $833M invested in Intellia Therapeutics in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 53 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

6% more capital invested

Capital invested by funds: $789M → $833M (+$43.6M)

1% more funds holding

Funds holding: 156 → 157 (+1)

0.41% more ownership

Funds ownership: 66.97% → 67.37% (+0.41%)

25% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 53

54% less call options, than puts

Call options by funds: $3.02M | Put options by funds: $6.49M

Holders
157
Holders Change
+1
Holders Change %
+0.64%
% of All Funds
3.59%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
21
Increased
40
Reduced
53
Closed
19
Calls
$3.02M
Puts
$6.49M
Net Calls
-$3.47M
Net Calls Change
-$4.53M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$36.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$8.37M
3
BlackRock
BlackRock
New York
+$5.47M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$4.8M
5
Deutsche Bank
Deutsche Bank
Germany
+$4.15M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$18.3M
2
BBA
Baker Bros. Advisors
New York
-$10.3M
3
FCM
Farallon Capital Management
California
-$8.44M
4
Morgan Stanley
Morgan Stanley
New York
-$7.69M
5
AVAI
Atlas Venture Associates IX
Massachusetts
-$6.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
GLA
26
Great Lakes Advisors
Illinois
$3.63M -$292K -10,033 -7%
Allianz Asset Management
27
Allianz Asset Management
Germany
$3.48M +$1.22M +41,765 +52%
WM
28
WS Management
Florida
$3.43M – – –
CS
29
Candriam SCA
Luxembourg
$3.43M +$591K +20,300 +20%
CAI
30
Capital Advisors Inc
Oklahoma
$3.15M +$67.7K +2,327 +2%
Goldman Sachs
31
Goldman Sachs
New York
$2.8M +$312K +10,711 +12%
Ameriprise
32
Ameriprise
Minnesota
$2.7M -$280K -9,640 -9%
AG
33
Artal Group
Luxembourg
$2.58M – – –
PP
34
PDT Partners
New York
$2.51M -$546K -18,783 -18%
GIM
35
Granahan Investment Management
Massachusetts
$2.36M -$1.11M -38,286 -32%
TA
36
Teachers Advisors
New York
$2.3M +$619K +21,286 +36%
Creative Planning
37
Creative Planning
Kansas
$2.23M -$13.6K -469 -0.6%
Neuberger Berman Group
38
Neuberger Berman Group
New York
$2.1M +$245K +8,405 +13%
FIM
39
Farmhouse Investment Management
California
$1.97M +$780K +26,800 +64%
TCM
40
Tekla Capital Management
Massachusetts
$1.97M -$2.87M -98,710 -59%
EWM
41
Elmwood Wealth Management
California
$1.87M +$145K +4,985 +8%
3C
42
361 Capital
Colorado
$1.84M +$1.87M +64,299 New
Wells Fargo
43
Wells Fargo
California
$1.8M -$251K -8,627 -12%
AllianceBernstein
44
AllianceBernstein
Tennessee
$1.68M – – –
Korea Investment Corp
45
Korea Investment Corp
South Korea
$1.66M -$279K -9,600 -14%
TCIM
46
TIAA CREF Investment Management
New York
$1.59M -$162K -5,566 -9%
PIM
47
Platinum Investment Management
Australia
$1.57M – – –
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$1.46M -$524 -18 -0%
Canada Life
49
Canada Life
Manitoba, Canada
$1.3M -$1.51M -51,921 -54%
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
$1.24M +$1.26M +43,188 New
1
2
3 4 5

NTLA Hedge Fund Activity: Q3 2018 in Review

157 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q3 2018, worth a combined $833M — up 5.5% from $789M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new NTLA positions and 19 closed out — a net gain of 2 holders — while 40 added to existing stakes and 53 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $36.1M. The largest seller was State Street, cutting an estimated $18.3M.

  • 157 institutional investors held Intellia Therapeutics (NTLA) as of Q3 2018, up from 156 in Q2 2018.
  • Funds reported $833M of Intellia Therapeutics stock for Q3 2018, up 5.5% quarter-over-quarter.
  • 21 funds opened new Intellia Therapeutics positions in Q3 2018 and 19 closed out, a net change of +2 holders.
  • The largest Intellia Therapeutics buyer in Q3 2018 was ARK Investment Management, an estimated $36.1M added.
  • The largest Intellia Therapeutics seller in Q3 2018 was State Street, an estimated $18.3M sold.

Based on aggregated 13F filings for Q3 2018.